Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Analysis of Expenditure In Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2014 In Spain.
Antigen-Specific Binding of Multivalent Soluble Antigen Arrays Induces Receptor Clustering and Impedes B Cell Receptor Mediated Signaling.
A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis.
[Hypomyelination with atrophy of the basal ganglia and cerebellum. Contribution of two new cases to a recently reported entity].
Clinical and neuroimaging correlation of movement disorders in multiple sclerosis: case series and review of the literature.
Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
A role for human brain pericytes in neuroinflammation.
A rare case of hyponatremia from a hypothalamic lesion in a patient with multiple sclerosis.
[Anaesthetic management of patient with neurological disease: Focus on regional anaesthesia.]
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis.
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis.
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.
Melatonin treatment improves primary progressive multiple sclerosis: a case report.
Altered thalamic functional connectivity in multiple sclerosis.
Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
A PheWAS approach in studying HLA-DRB1*1501.
An early British case of neuromyelitis optica (1850).
In vivo immunomodulatory effect of the lectin from edible mushroom Agaricus bisporus.
Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease.
Sensory dynamic orthoses in mild to moderate upper limb tremor in multiple sclerosis: A mixed methods feasibility study.
The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients.
Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.
Erratum.
Empyema presenting as lower extremity weakness.
Activation-induced cell death in T lymphocytes from multiple sclerosis patients.
Pages
« first
‹ previous
…
398
399
400
401
402
403
404
405
406
…
next ›
last »